Skip to main content

Salvia BioElectronics

Eindhoven, The Netherlands

Salvia BioElectronics develops neuromodulation devices for migraine treatment and management.

$60.4M raised
May 2025
Series B

Top Investors

Invest-NLInnovation IndustriesPanakes PartnersInkefSHS Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Salvia BioElectronics

How much funding has Salvia BioElectronics raised?
Salvia BioElectronics has raised $60.4M in total funding. The most recent round was Series B. The last funding was announced in May 2025.
Who are Salvia BioElectronics's investors?
Salvia BioElectronics's investors include Invest-NL, Innovation Industries, Panakes Partners, Inkef, SHS Capital.
Where is Salvia BioElectronics headquartered?
Salvia BioElectronics is headquartered in Eindhoven, The Netherlands.
What does Salvia BioElectronics do?
Salvia BioElectronics develops neuromodulation devices for migraine treatment and management.
What stage is Salvia BioElectronics at?
Salvia BioElectronics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Salvia BioElectronics — Funding & Investors." VCBacked, May 27, 2025, https://www.vcbacked.co/company/salvia-bioelectronics. Accessed June 5, 2026.
APA
VCBacked. (2025). Salvia BioElectronics — Funding & Investors. Retrieved June 5, 2026, from https://www.vcbacked.co/company/salvia-bioelectronics
Wikipedia (cite web)
{{cite web |title=Salvia BioElectronics — Funding & Investors |url=https://www.vcbacked.co/company/salvia-bioelectronics |website=VCBacked |access-date=June 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .